August 19, 2020
Via: MedPageTodayPatients hospitalized with mild COVID-19 in China exhibited a wide range of SARS-CoV-2-specific neutralizing antibodies, with a minority of patients with levels below the detectable limit of the assay, researchers found. Out of 175 patients, 30% developed SARS-CoV-2-specific neutralizing antibody […]
February 28, 2024